Technical Analysis for GWPH - GW Pharmaceuticals Plc

Grade Last Price % Change Price Change
grade B 168.11 -0.30% -0.50
GWPH closed down 0.3 percent on Tuesday, March 19, 2019, on 56 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical GWPH trend table...

Date Alert Name Type % Chg
Mar 19 Hammer Candlestick Bullish 0.00%
Mar 18 Multiple of Ten Bearish Other -0.30%
Mar 15 180 Bullish Setup Bullish Swing Setup -0.71%
Mar 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.71%
Mar 15 Multiple of Ten Bearish Other -0.71%
Mar 14 Multiple of Ten Bearish Other 0.92%
Mar 13 Bearish Engulfing Bearish -0.72%
Mar 13 Multiple of Ten Bearish Other -0.72%
Mar 13 Outside Day Range Expansion -0.72%
Mar 12 Golden Cross Bullish -1.67%

Older signals for GWPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain. In addition, the company has two product candidates in Phase II trials in the field of diabetes and inflammation, as well as pre-clinical research programmes evaluating the use of selected cannabinoids for the treatment of glioma, epilepsy, and psychiatric illness. It has a strategic alliance with Otsuka Pharmaceutical Co. Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.
Health Cancer Pharmaceutical Industry Pain Drugs Diabetes Treatment Of Cancer Medication Inflammation Pharmaceutical Industry In China Pharmaceuticals Policy Cannabis Epilepsy Glioma Cannabinoids Neuropathic Pain
Is GWPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 182.23
52 Week Low 90.14
Average Volume 514,441
200-Day Moving Average 141.3101
50-Day Moving Average 148.4796
20-Day Moving Average 164.743
10-Day Moving Average 167.739
Average True Range 6.327
ADX 28.85
+DI 30.8984
-DI 19.2042
Chandelier Exit (Long, 3 ATRs ) 163.249
Chandelier Exit (Short, 3 ATRs ) 159.421
Upper Bollinger Band 184.376
Lower Bollinger Band 145.11
Percent B (%b) 0.59
BandWidth 23.8347
MACD Line 6.1421
MACD Signal Line 7.2556
MACD Histogram -1.1135
Fundamentals Value
Market Cap 4.26 Billion
Num Shares 25.4 Million
EPS -5.64
Price-to-Earnings (P/E) Ratio -29.81
Price-to-Sales 253.36
Price-to-Book 6.23
PEG Ratio 0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 174.85
Resistance 3 (R3) 174.56 172.04 173.72
Resistance 2 (R2) 172.04 170.32 172.18 173.35
Resistance 1 (R1) 170.07 169.26 168.81 170.36 172.97
Pivot Point 167.55 167.55 166.92 167.69 167.55
Support 1 (S1) 165.58 165.83 164.32 165.87 163.25
Support 2 (S2) 163.06 164.77 163.20 162.87
Support 3 (S3) 161.09 163.06 162.50
Support 4 (S4) 161.38